Events After the End of the Reporting Period

Increasing the plan assets of Bayer Pension Trust e.V.

On April 19, 2016, Bayer AG increased the coverage of Bayer Pension Trust e.V. with the deposit of 10 million of the shares it held in Covestro AG. The number of shares deposited amounted to 4.9% of the shares outstanding.

Repayment of financial liabilities

On April 4, 2016, Bayer Nordic SE repaid on schedule a bond with a nominal volume of €200 million.

Patent term extension for rivaroxaban

In April 2016, the U.S. Patent and Trademark Office granted a patent term extension for rivaroxaban (the active pharmaceutical ingredient of Xarelto™). The patent protection of the active ingredient in the United States now expires in 2024.

Leverkusen, April 22, 2016
Bayer Aktiengesellschaft

The Board of Management

Dr. Marijn Dekkers

Werner Baumann

Liam Condon

Johannes Dietsch

Dr. Hartmut Klusik

Kemal Malik

Erica Mann

Dieter Weinand